RituximabCOVID-19 infection: 2 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2020年 / 1833卷 / 1期

关键词：

D O I：

10.1007/s40278-020-87160-5

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：342 / 342

相关论文

共 50 条

[1] RituximabCOVID-19 infection: 2 case reports
Reactions Weekly, 2022, 1897 (1) : 324 - 324
[2] Ocrelizumab/rituximabCOVID-19 infection: 2 case reports
Reactions Weekly, 2021, 1870 (1) : 258 - 258
[3] RituximabCOVID-19 infection: 3 case reports
Reactions Weekly, 2021, 1846 (1) : 283 - 283
[4] RituximabCOVID-19: 2 case reports
Reactions Weekly, 2021, 1843 (1) : 318 - 318
[5] RituximabCOVID-19 infection: 8 case reports
Reactions Weekly, 2021, 1872 (1) : 440 - 440
[6] RituximabCOVID-19: 2 case reports
Reactions Weekly, 2022, 1908 (1) : 494 - 494
[7] RituximabCOVID-19 respiratory infection: 9 case reports
Reactions Weekly, 2021, 1863 (1) : 301 - 301
[8] Infliximab/rituximabCOVID-19 infection: 10 case reports
Reactions Weekly, 2022, 1895 (1) : 221 - 221
[9] Immunosuppressants/rituximabCOVID-19 infection: 23 case reports
Reactions Weekly, 2022, 1913 (1) : 254 - 254
[10] RituximabCOVID-19 infection: case report
Reactions Weekly, 2024, 2023 (1) : 360 - 360

← 1 2 3 4 5 →